How the African clawed frog became a model organism

Most model organisms earn their place in the lab because someone sets out deliberately to find a good genetic system. The African clawed frog, Xenopus laevis, did not. It became one of the most widely used vertebrates in developmental and molecular biology largely as a side effect of a diagnostic test for human pregnancy, one that had nothing to do with embryology at all. By the time researchers started asking serious questions about how a single fertilised egg becomes a whole animal, thousands of these frogs were already sitting in tanks in hospitals and university departments around the world, bred and shipped as a matter of routine. The developmental biologists did not have to introduce the species. They just had to notice it was already there.

A colonial physiology department and an accidental hormone assay

The story starts in Cape Town in the late 1920s. Lancelot Hogben, a British zoologist, took up the chair of zoology at the University of Cape Town in 1927. He was interested at the time in the physiology of colour change in amphibians, and specifically in how the pituitary gland controlled pigment cells in the skin of Xenopus laevis, a fully aquatic, tongueless frog native to sub-Saharan Africa. Hogben found that removing a Xenopus frog's pituitary gland caused it to lose its ability to darken, and that injecting pituitary extract restored the response.

While working on that pigment system, Hogben and colleagues noticed something unrelated to camouflage: injecting Xenopus females with pituitary extract, initially from oxen, made them ovulate, releasing eggs within hours rather than waiting for a natural breeding cycle. That observation on its own was an interesting piece of endocrinology. It became something much bigger once someone made the connection to human chorionic gonadotropin, the hormone produced by the placenta in early pregnancy, which acts on the body in a broadly similar way to the pituitary hormones controlling ovulation. If Xenopus ovulated in response to gonadotropin generally, it should also ovulate in response to the gonadotropin present in the urine of a pregnant woman.

Turning that idea into a usable clinical test was largely the work of two researchers at the University of Cape Town, Hillel Shapiro and Harry Zwarenstein, both of whom had been Hogben's students. In October 1933 they reported to the Royal Society of South Africa that they had successfully used Xenopus in 35 pregnancy tests, injecting a woman's urine into a female frog and checking for egg-laying within a day. The method worked well, was fast by the standards of the day, and, unlike the mouse and rabbit assays used at the time, did not require killing the animal to read the result. A single frog could be reused for test after test.

What followed was a genuinely unusual academic dispute. The zoologist Francis Crew proposed naming the method the "Hogben test" in 1939, prompting objections from within the University of Cape Town's own physiology department, where Shapiro and Zwarenstein felt the credit for the specific pregnancy application belonged to them rather than to Hogben, whose original published work on Xenopus ovulation had not mentioned pregnancy testing at all. A campaign to call it the "Xenopus test" instead never displaced the rival name in Britain, and "Hogben test" is what stuck in the medical literature for the next three decades.

A pregnancy test with a twenty-year run

The Hogben test spread quickly through the 1930s and 1940s and remained in routine clinical use into the 1960s, cited in some reviews as reaching close to 99% accuracy in the hands of an experienced technician. Hospitals and diagnostic laboratories on several continents needed a reliable, continuously breeding supply of Xenopus laevis to run it, which meant importing live frogs from southern Africa and setting up colonies to keep them alive and fecund. That demand is the reason Xenopus ended up distributed across Europe, North America, Asia and Australia well before most biologists had any interest in frog embryology as such. The species had, in effect, already been domesticated for laboratory life, complete with established husbandry practices, before anyone started asking developmental questions of it.

The test's dominance ended once immunological methods for detecting human chorionic gonadotropin, first haemagglutination inhibition assays and later antibody-based tests, became available from the 1960s onwards. These required no animals, gave faster results, and were cheaper to run at scale, so hospital frog colonies gradually became redundant. Some were released rather than destroyed, which is part of the reason feral Xenopus laevis populations still turn up today in places such as California, Wales and Chile, well outside the species' native range.

But by the time the pregnancy test era ended, Xenopus had already found its next job. Colonies established for clinical use provided a ready population for a very different kind of laboratory, and one figure in particular was about to make the species' scientific reputation.

Why embryologists liked what they found

Independently of the pregnancy-testing trade, biologists working on early development had reasons of their own to like Xenopus laevis. Michael Fischberg, a biologist working at the University of Oxford, maintained one of the significant Xenopus colonies used for this purpose and identified a naturally occurring genetic marker, a difference in nucleolar number between two subspecies, that would turn out to be extremely useful for tracking whose genetic material ended up where in an experiment.

The frog itself had practical virtues that made it attractive quite apart from any test kit. Its eggs are large by vertebrate standards, roughly a millimetre across, robust enough to survive being handled with fine forceps and a needle, and produced in the hundreds by a single hormone-primed female on demand, the very same injection-triggered ovulation that made the pregnancy test possible. Fertilisation happens outside the body, so every stage from a one-cell egg onwards can be watched and manipulated directly, without surgery on the mother. For anyone trying to move a nucleus from one cell into another, or to microinject material into an embryo and watch what happened next, those were close to ideal starting conditions.

Gurdon, nuclear transfer, and the reversibility of development

It was in this setting that John Gurdon, working on his doctorate at Oxford under Fischberg's supervision, ran the experiments that would eventually define the frog's scientific reputation. In 1958, Gurdon, together with Thomas Elsdale and Fischberg, published a paper in Nature reporting that nuclei taken from Xenopus laevis embryonic cells and transplanted into eggs whose own nuclei had been destroyed could support development all the way through to sexually mature, fertile adult frogs. Fischberg's nucleolar marker was what let them prove, cell by cell, that the resulting frogs really had developed from the transplanted donor nucleus and not from any residual material of the host egg.

Gurdon then pushed the experiment further, toward cells that were unambiguously more specialised. In a 1962 paper in the Journal of Embryology and Experimental Morphology, he reported transplanting nuclei from the differentiated intestinal epithelium cells of feeding tadpoles, cells with a distinctive brush border marking them out as a committed, specialised tissue, and showing that some of these nuclei could still direct the development of an enucleated egg into a normal tadpole. That result ran directly against the prevailing assumption in the field, based partly on earlier nuclear transfer work in frogs by Robert Briggs and Thomas King, that as a cell specialises it permanently loses genetic potential it no longer needs. Gurdon's experiments showed instead that the genome of a differentiated cell remains, in the right cytoplasmic environment, capable of directing an entire new organism.

"I believe he has ideas about becoming a scientist; on his present showing this is quite ridiculous."

That is what a biology teacher wrote of the teenage John Gurdon on a school report at Eton in 1949, a document Gurdon later kept framed above his desk. It is a nice historical footnote precisely because the record is so clear on how wrong the prediction turned out to be. Decades after the Xenopus nuclear transfer experiments, the principle they established, that a differentiated cell's genome can be reprogrammed back to an earlier, more flexible state, became the conceptual foundation for induced pluripotent stem cell technology. In 2012 Gurdon shared the Nobel Prize in Physiology or Medicine with Shinya Yamanaka, whose own work reprogrammed adult mouse and human cells directly into pluripotent stem cells using defined transcription factors, "for the discovery that mature cells can be reprogrammed to become pluripotent." Gurdon died in October 2025, at the age of 92.

A frog that kept being useful

Xenopus laevis did not stop mattering once nuclear transfer had made its point. Its eggs turned out to be just as valuable ground up as they were whole. Through the 1980s, researchers including Yoshio Masui, whose earlier work on oocyte maturation had already identified a cytoplasmic factor capable of driving cells into division, helped establish methods for preparing cell-free extracts from frog eggs, essentially all of the biochemical machinery needed to run a cell cycle, decanted into a test tube. In 1989, Andrew Murray and Marc Kirschner used exactly this kind of Xenopus egg extract to show directly that the synthesis and destruction of a protein called cyclin was sufficient, on its own, to drive the oscillations of the early embryonic cell cycle, a result that helped tie together genetic and biochemical views of how cells decide when to divide.

That extract system is still in active use today, for questions well beyond the cell cycle: DNA replication, chromosome condensation, nuclear envelope assembly, and the self-organisation of the microtubule cytoskeleton have all been dissected in cell-free Xenopus egg preparations, because the extract keeps performing the relevant biochemistry outside a living cell, in a dish, where it can be manipulated directly.

More recently, molecular genetics has caught up with the frog itself. Xenopus laevis has a complicated, allotetraploid genome, the product of an ancient hybridisation between two ancestral species, which complicates classical genetic analysis. Its smaller, diploid relative Xenopus tropicalis does not have that complication, and has become the preferred species for genome editing work. In 2013, a team led by Takuya Nakayama reported a simple and efficient method for CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis, demonstrating it with visible loss-of-function phenotypes in genes controlling pigmentation and eye and brain development. That paper, alongside the sequencing of the X. tropicalis genome, has kept the frog current as a genome-editing model well into the CRISPR era, rather than leaving it as a historical curiosity.

An organism built by accident, twice over

It is worth sitting with how little of this was planned. Nobody set out to build a developmental biology model when Hogben went looking for a hormone assay in Cape Town, and nobody at the University of Cape Town's physiology department in the early 1930s was thinking about nuclear reprogramming or cell-free extracts when Shapiro and Zwarenstein worked out how to read a pregnancy result from frog ovulation. What they built instead was a distribution network and a husbandry practice: a reliable, well-understood way to keep large numbers of Xenopus laevis alive, healthy, and ready to ovulate on command, in laboratories on nearly every continent.

That infrastructure, not any early recognition of the frog's developmental promise, is what put Xenopus within reach of Fischberg's colony at Oxford and, through him, of Gurdon's nuclear transfer experiments. Everything that followed, the 2012 Nobel Prize, decades of cell-cycle biochemistry done in egg extracts, and a modern CRISPR toolkit built around the frog's diploid cousin, rests on a species that became a laboratory animal for reasons that had nothing to do with any of it.